{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:13:33Z","timestamp":1790856813336,"version":"4.1.0"},"reference-count":29,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81230052"],"award-info":[{"award-number":["81230052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630006"],"award-info":[{"award-number":["81630006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770211"],"award-info":[{"award-number":["81770211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873452"],"award-info":[{"award-number":["81873452"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2016CFA011"],"award-info":[{"award-number":["2016CFA011"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2018ACA140"],"award-info":[{"award-number":["2018ACA140"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40425-019-0767-x","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T10:26:01Z","timestamp":1571826361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy"],"prefix":"10.1136","volume":"7","author":[{"given":"Hui","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"issue":"224","key":"767_CR1","doi-asserted-by":"publisher","first-page":"224ra25","DOI":"10.1126\/scitranslmed.3008226","volume":"6","author":"ML Davila","year":"2014","unstructured":"Davila ML, Riviere I, Wang X, et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Scie Transl Med. 2014;6(224):224ra25.","journal-title":"Scie Transl Med"},{"issue":"1","key":"767_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nm.4441","volume":"24","author":"TJ Fry","year":"2018","unstructured":"Fry TJ, Shah NN, Orentas RJ, et al. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med. 2018;24(1):20\u20138.","journal-title":"Nat Med"},{"issue":"22","key":"767_CR3","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1200\/JCO.2018.77.8084","volume":"36","author":"JN Brudno","year":"2018","unstructured":"Brudno JN, Maric I, Hartman SD, et al. T cells genetically modified to express an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma. J Clin Oncol. 2018;36(22):2267\u201380.","journal-title":"J Clin Oncol"},{"issue":"5","key":"767_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"Maude SL, Laetsch TW, Buechner J, et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med. 2018;378(5):439\u201348.","journal-title":"N Engl J Med"},{"issue":"1","key":"767_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1056\/NEJMoa1804980","volume":"380","author":"SJ Schuster","year":"2019","unstructured":"Schuster SJ, Bishop MR, Tam CS, et al. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N Engl J Med. 2019;380(1):45\u201356.","journal-title":"N Engl J Med"},{"issue":"24","key":"767_CR6","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1182\/blood-2015-12-686725","volume":"127","author":"X Wang","year":"2016","unstructured":"Wang X, Popplewell LL, Wagner JR, et al. Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL. Blood. 2016;127(24):2980\u201390.","journal-title":"Blood"},{"issue":"4","key":"767_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1158\/1078-0432.CCR-18-3328","volume":"25","author":"Mark B. Geyer","year":"2018","unstructured":"Geyer MB. First CAR to Pass the Road Test: Tisagenlecleucel\u2019s Drive to FDA Approval. Clin Cancer Res. 2019;25(4):1133-5.","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"767_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","volume":"15","author":"SS Neelapu","year":"2018","unstructured":"Neelapu SS, Tummala S, Kebriaei P, et al. Chimeric antigen receptor T-cell therapy - assessment and management of toxicities. Nat Rev Clin Oncol. 2018;15(1):47\u201362.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"767_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00134-017-4943-5","volume":"44","author":"P Godel","year":"2018","unstructured":"Godel P, Shimabukuro-Vornhagen A, von Bergwelt-Baildon M. Understanding cytokine release syndrome. Intensive Care Med. 2018;44(3):371\u20133.","journal-title":"Intensive Care Med"},{"issue":"2","key":"767_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","volume":"124","author":"DW Lee","year":"2014","unstructured":"Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124(2):188\u201395.","journal-title":"Blood"},{"issue":"4","key":"767_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/cid\/ciy152","volume":"67","author":"JH Park","year":"2018","unstructured":"Park JH, Romero FA, Taur Y, et al. Cytokine release syndrome grade as a predictive marker for infections in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with chimeric antigen receptor T cells. Clin Infect Dis. 2018;67(4):533\u201340.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"767_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1182\/blood-2017-07-793760","volume":"131","author":"JA Hill","year":"2018","unstructured":"Hill JA, Li D, Hay KA, et al. Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy. Blood. 2018;131(1):121\u201330.","journal-title":"Blood"},{"issue":"9","key":"767_CR13","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/cid\/cix603","volume":"65","author":"EJ Septimus","year":"2017","unstructured":"Septimus EJ, Coopersmith CM, Whittle J, Hale CP, Fishman NO, Kim TJ. Sepsis National Hospital Inpatient Quality Measure (SEP-1): multistakeholder work group recommendations for appropriate antibiotics for the treatment of Sepsis. Clin Infect Dis. 2017;65(9):1565\u20139.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"767_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00134-012-2752-4","volume":"39","author":"XJ Xu","year":"2013","unstructured":"Xu XJ, Tang YM, Liao C, et al. Inflammatory cytokine measurement quickly discriminates gram-negative from gram-positive bacteremia in pediatric hematology\/oncology patients with septic shock. Intensive Care Med. 2013;39(2):319\u201326.","journal-title":"Intensive Care Med"},{"issue":"6","key":"767_CR15","first-page":"669","volume":"27","author":"H Chaudhry","year":"2013","unstructured":"Chaudhry H, Zhou J, Zhong Y, et al. Role of cytokines as a double-edged sword in sepsis. In Vivo. 2013;27(6):669\u201384.","journal-title":"In Vivo"},{"issue":"12","key":"767_CR16","doi-asserted-by":"publisher","first-page":"e1005973","DOI":"10.1371\/journal.ppat.1005973","volume":"12","author":"J Slaats","year":"2016","unstructured":"Slaats J, Ten Oever J, van de Veerdonk FL, Netea MG. IL-1beta\/IL-6\/CRP and IL-18\/ferritin: distinct inflammatory programs in infections. PLoS Pathog. 2016;12(12):e1005973.","journal-title":"PLoS Pathog"},{"key":"767_CR17","doi-asserted-by":"crossref","unstructured":"Liang H, et al. CAR22\/19 Cocktail Therapy for Patients with Refractory\/Relapsed B-Cell Malignancies. 59th American Society of Hematology Annual Meeting, 2017. Abstract # 1408.","DOI":"10.1182\/blood-2018-99-113714"},{"key":"767_CR18","doi-asserted-by":"crossref","unstructured":"Chunrui L, et al. T Cells Expressing Anti B-Cell Maturation Antigen Chimeric Antigen Receptors for Plasma Cell Malignancies. 60th American Society of Hematology Annual Meeting, 2018. Abstract # 1013.","DOI":"10.1182\/blood-2018-99-116898"},{"issue":"1","key":"767_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13045-018-0672-7","volume":"11","author":"J Xu","year":"2018","unstructured":"Xu J, Wang Q, Xu H, et al. Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma. J Hematol Oncol. 2018;11(1):128.","journal-title":"J Hematol Oncol"},{"key":"767_CR20","doi-asserted-by":"crossref","unstructured":"Yang C, et al. Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells Following Autologous HSCT in Patients with B-NHL. 60th American Society of Hematology Annual Meeting, 2018. Abstract # 2054.","DOI":"10.1182\/blood-2018-99-113827"},{"issue":"8","key":"767_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11626-018-0273-3","volume":"54","author":"H Xu","year":"2018","unstructured":"Xu H, Wang N, Cao W, Huang L, Zhou J, Sheng L. Influence of various medium environment to in vitro human T cell culture. In Vitro Cell Dev Biol Anim. 2018;54(8):559\u201366.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"767_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cryobiol.2018.06.007","volume":"83","author":"H Xu","year":"2018","unstructured":"Xu H, Cao W, Huang L, et al. Effects of cryopreservation on chimeric antigen receptor T cell functions. Cryobiology. 2018;83:40\u20137.","journal-title":"Cryobiology"},{"issue":"12","key":"767_CR23","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.bbmt.2007.08.049","volume":"13","author":"JA Burik van","year":"2007","unstructured":"van Burik JA, Carter SL, Freifeld AG, et al. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease. Biol Blood Marrow Transplant. 2007;13(12):1487\u201398.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"767_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.arcmed.2016.08.004","volume":"47","author":"Y Long","year":"2016","unstructured":"Long Y, Zhang Y, Gong Y, et al. Diagnosis of Sepsis with cell-free DNA by next-generation sequencing technology in ICU patients. Arch Med Res. 2016;47(5):365\u201371.","journal-title":"Arch Med Res"},{"issue":"12","key":"767_CR25","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases mycoses study group (EORTC\/MSG) consensus group. Clin Infect Dis. 2008;46(12):1813\u201321.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"767_CR26","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/ndt\/gfq046","volume":"25","author":"G Tripepi","year":"2010","unstructured":"Tripepi G, Jager KJ, Dekker FW, Zoccali C. Statistical methods for the assessment of prognostic biomarkers (part II): calibration and re-classification. Nephrol Dial Transplant. 2010;25(5):1402\u20135.","journal-title":"Nephrol Dial Transplant"},{"issue":"21","key":"767_CR27","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","volume":"130","author":"KA Hay","year":"2017","unstructured":"Hay KA, Hanafi LA, Li D, et al. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. Blood. 2017;130(21):2295\u2013306.","journal-title":"Blood"},{"issue":"6","key":"767_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","volume":"6","author":"DT Teachey","year":"2016","unstructured":"Teachey DT, Lacey SF, Shaw PA, et al. Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Cancer Discov. 2016;6(6):664\u201379.","journal-title":"Cancer Discov"},{"issue":"6","key":"767_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/0962280206070637","volume":"15","author":"CT Le","year":"2006","unstructured":"Le CT. A solution for the most basic optimization problem associated with an ROC curve. Stat Methods Med Res. 2006;15(6):571\u201384.","journal-title":"Stat Methods Med Res"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40425-019-0767-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:45:27Z","timestamp":1601055927000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-019-0767-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["767"],"URL":"https:\/\/doi.org\/10.1186\/s40425-019-0767-x","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"15 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All samples were used after by the Institutional Review Board and informed consent was obtained from each individual in strict accordance with the principles in Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"271"}}